These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


374 related items for PubMed ID: 15751093

  • 1. Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.
    Kim TH, Stone M, Payne U, Zhang X, Ionescu M, Lobanok T, King L, Poole AR, Inman RD.
    Arthritis Rheum; 2005 Mar; 52(3):885-91. PubMed ID: 15751093
    [Abstract] [Full Text] [Related]

  • 2. Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
    Maksymowych WP, Poole AR, Hiebert L, Webb A, Ionescu M, Lobanok T, King L, Davis JC.
    J Rheumatol; 2005 Oct; 32(10):1911-7. PubMed ID: 16206346
    [Abstract] [Full Text] [Related]

  • 3. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ.
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [Abstract] [Full Text] [Related]

  • 4. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
    Cibere J, Thorne A, Kopec JA, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Lobanok T, Ionescu M, Poole AR, Esdaile JM.
    J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
    [Abstract] [Full Text] [Related]

  • 5. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.
    Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB.
    Arthritis Rheum; 2006 Aug; 54(8):2496-504. PubMed ID: 16868970
    [Abstract] [Full Text] [Related]

  • 6. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
    Squires GR, Okouneff S, Ionescu M, Poole AR.
    Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
    [Abstract] [Full Text] [Related]

  • 7. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
    Woo JH, Lee HJ, Sung IH, Kim TH.
    J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317
    [Abstract] [Full Text] [Related]

  • 8. Serum concentrations of type II collagen biomarkers (C2C, C1, 2C and CPII) suggest different pathophysiologies in patients with hip osteoarthritis.
    Conrozier T, Poole AR, Ferrand F, Mathieu P, Vincent F, Piperno M, Verret C, Ionescu M, Vignon E.
    Clin Exp Rheumatol; 2008 Aug; 26(3):430-5. PubMed ID: 18578964
    [Abstract] [Full Text] [Related]

  • 9. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid.
    Céleste C, Ionescu M, Robin Poole A, Laverty S.
    J Orthop Res; 2005 May; 23(3):602-10. PubMed ID: 15885481
    [Abstract] [Full Text] [Related]

  • 10. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW, Roosendaal G, Lundin B, Heijnen L, Mauser-Bunschoten E, Bijlsma JW, Theobald M, Lafeber FP.
    Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
    [Abstract] [Full Text] [Related]

  • 11. Matrix homeostasis in aging normal human ankle cartilage.
    Aurich M, Poole AR, Reiner A, Mollenhauer C, Margulis A, Kuettner KE, Cole AA.
    Arthritis Rheum; 2002 Nov; 46(11):2903-10. PubMed ID: 12428230
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.
    Niki Y, Takeuchi T, Nakayama M, Nagasawa H, Kurasawa T, Yamada H, Toyama Y, Miyamoto T.
    PLoS One; 2012 Nov; 7(5):e37447. PubMed ID: 22629396
    [Abstract] [Full Text] [Related]

  • 13. Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints.
    Aurich M, Squires GR, Reiner A, Mollenhauer JA, Kuettner KE, Poole AR, Cole AA.
    Arthritis Rheum; 2005 Jan; 52(1):112-9. PubMed ID: 15641059
    [Abstract] [Full Text] [Related]

  • 14. Inflammatory biomarkers, disease activity and spinal disease measures in patients with ankylosing spondylitis after treatment with infliximab.
    Visvanathan S, Wagner C, Marini JC, Baker D, Gathany T, Han J, van der Heijde D, Braun J.
    Ann Rheum Dis; 2008 Apr; 67(4):511-7. PubMed ID: 17644552
    [Abstract] [Full Text] [Related]

  • 15. Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.
    Verstappen SM, Poole AR, Ionescu M, King LE, Abrahamowicz M, Hofman DM, Bijlsma JW, Lafeber FP, Utrecht Rheumatoid Arthritis Cohort Study group (SRU).
    Arthritis Res Ther; 2006 Apr; 8(1):R31. PubMed ID: 16507130
    [Abstract] [Full Text] [Related]

  • 16. Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.
    de Vries MK, van Eijk IC, van der Horst-Bruinsma IE, Peters MJ, Nurmohamed MT, Dijkmans BA, Hazenberg BP, Wolbink GJ.
    Arthritis Rheum; 2009 Nov 15; 61(11):1484-90. PubMed ID: 19877087
    [Abstract] [Full Text] [Related]

  • 17. Changes in serum cartilage marker levels indicate altered cartilage metabolism in families with the osteoarthritis-related type II collagen gene COL2A1 mutation.
    Bleasel JF, Poole AR, Heinegård D, Saxne T, Holderbaum D, Ionescu M, Jones P, Moskowitz RW.
    Arthritis Rheum; 1999 Jan 15; 42(1):39-45. PubMed ID: 9920012
    [Abstract] [Full Text] [Related]

  • 18. Divergent diagnosis from arthroscopic findings and identification of CPII and C2C for detection of cartilage degradation in horses.
    Lettry V, Sumie Y, Mitsuda K, Tagami M, Hosoya K, Takagi S, Okumura M.
    Jpn J Vet Res; 2010 Feb 15; 57(4):197-206. PubMed ID: 20364792
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.
    Ann Rheum Dis; 2008 Mar 15; 67(3):353-7. PubMed ID: 17644538
    [Abstract] [Full Text] [Related]

  • 20. Effects of etanercept on serum biochemical markers of cartilage metabolism in patients with spondyloarthropathy.
    Briot K, Roux C, Gossec L, Charni N, Kolta S, Dougados M, Garnero P.
    J Rheumatol; 2008 Feb 15; 35(2):310-4. PubMed ID: 18203315
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.